Your account is not claimed yet. You can sign up with ORCID to claim your account.

Harri Jaakko Sihto (Harri J Sihto, Harri Sihto)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 27

Top Venues

International journal of cancer

Nature communications

PloS one

Cancers

University of Helsinki

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Helsinki Nov 1o 2018

Finland

University researcher :: Department of Pathology

Publications

Heikki Joensuu, Eva Wardelmann, Mikael Eriksson, Annette Reichardt, Kirsten Sundby Hall, Jochen Schütte, Silke Cameron, Peter Hohenberger, Harri Jaakko Sihto, Philipp J Jost, Lars H Lindner, Sebastian Bauer, Bengt Nilsson, Raija Kallio, Tommi Pesonen, Peter Reichardt
KIT And PDGFRA Mutations And Survival of Gastrointestinal Stromal Tumor Patients Treated With Adjuvant Imatinib in a Randomized Trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Kirsi Toivanen, Sami K Kilpinen, Kalle Ojala, Nanna Merikoski, Sami Salmikangas, Mika Sampo, Tom O Böhling, Harri Jaakko Sihto
PDE3A Is a Highly Expressed Therapy Target in Myxoid Liposarcoma. Cancers 15 (22) (2023)
Marko Salmikangas, Maria Laaksonen, Henrik Edgren, Marco Salgado, Anu Suoranta, Pirkko Mattila, Virve Koljonen, Tom Böhling, Harri Jaakko Sihto
Neurocan expression associates with better survival and viral positivity in Merkel cell carcinoma. PloS one 18 (5) (2023)
Benjamin Zacharias Sundqvist, Sami K Kilpinen, Tom O Böhling, Virve S K Koljonen, Harri Jaakko Sihto
Transcriptomic analyses reveal three distinct molecular subgroups of Merkel cell carcinoma with differing prognoses. International journal of cancer 152 (10) (2023)
Benjamin Zacharias Sundqvist, Sami K Kilpinen, Tom O Böhling, Virve S K Koljonen, Harri Jaakko Sihto
Transcriptomic analyses reveal three distinct molecular subgroups of Merkel cell carcinoma with differing prognoses. International journal of cancer 152 (10) (2023)
Benjamin Zacharias Sundqvist, Sami K Kilpinen, Tom O Böhling, Virve S K Koljonen, Harri Jaakko Sihto
Transcriptomic analyses reveal three distinct molecular subgroups of Merkel cell carcinoma with differing prognoses. International journal of cancer (2023)
Marko Salmikangas, Maria Laaksonen, Henrik Edgren, Marco Salgado, Anu Suoranta, Pirkko Mattila, Virve Koljonen, Tom Böhling, Harri Jaakko Sihto
Neurocan expression associates with better survival and viral positivity in Merkel cell carcinoma. PloS one 18 (5) (2023)
Benjamin Zacharias Sundqvist, Sami Kalevi Kilpinen, Tom Ove Böhling, Virve Sanna Kristiina Koljonen, Harri Jaakko Sihto
Transcriptomic Analyses Reveal Three Distinct Molecular Subgroups of Merkel Cell Carcinoma with Differing Prognoses. International journal of cancer (2023)
Benjamin Zacharias Sundqvist, Sami K Kilpinen, Tom O Böhling, Virve S K Koljonen, Harri Jaakko Sihto
Transcriptomic analyses reveal three distinct molecular subgroups of Merkel cell carcinoma with differing prognoses. International journal of cancer 152 (10) (2023)
Marko Salmikangas, Maria Laaksonen, Henrik Edgren, Marco Salgado, Anu Suoranta, Pirkko Mattila, Virve Koljonen, Tom Böhling, Harri Jaakko Sihto
Neurocan expression associates with better survival and viral positivity in Merkel cell carcinoma. PloS one 18 (5) (2023)
Benjamin Zacharias Sundqvist, Sami K Kilpinen, Tom O Böhling, Virve S K Koljonen, Harri Jaakko Sihto
Transcriptomic analyses reveal three distinct molecular subgroups of Merkel cell carcinoma with differing prognoses. International journal of cancer 152 (10) (2023)
Benjamin Zacharias Sundqvist, Sami Kilpinen, Tom O Böhling, Virve Koljonen, Harri Jaakko Sihto
Activation of Oncogenic and Immune-Response Pathways Is Linked to Disease-Specific Survival in Merkel Cell Carcinoma. Cancers 14 (15) (2022)
Anni I Soikkeli, Minna K Kyläniemi, Harri Jaakko Sihto, Jukka Alinikula
Oncogenic Merkel Cell Polyomavirus T Antigen Truncating Mutations are Mediated by APOBEC3 Activity in Merkel Cell Carcinoma. Cancer research communications 2 (11) (2022)
Anni I Soikkeli, Minna K Kyläniemi, Harri Jaakko Sihto, Jukka Alinikula
Oncogenic Merkel Cell Polyomavirus T Antigen Truncating Mutations are Mediated by APOBEC3 Activity in Merkel Cell Carcinoma. Cancer research communications 2 (11) (2022)
Olli-Pekka Pulkka, Leevi Viisanen, Olli Tynninen, Maria Laaksonen, Peter Reichardt, Annette Reichardt, Mikael Eriksson, Kirsten Sundby Hall, Eva Wardelmann, Bengt Nilsson, Harri Jaakko Sihto, Heikki Joensuu
Fibrinogen-like protein 2 in gastrointestinal stromal tumour. Journal of cellular and molecular medicine 26 (4) (2022)
Sami Salmikangas, Tom O Böhling, Nanna Merikoski, Joanna Jagdeo, Mika Sampo, Tiina Vesterinen, Harri Jaakko Sihto
Tensin2 Is a Novel Diagnostic Marker in GIST, Associated with Gastric Location and Non-Metastatic Tumors. Cancers 14 (13) (2022)
Kashif Rasheed, Valeria Pietropaolo, Benedetta Policastro, John Inge Johnsen, Virve Koljonen, Harri Jaakko Sihto, Weng-Onn Lui, Baldur Sveinbjørnsson
The Merkel Cell Polyomavirus T-Antigens and IL-33/ST2-IL1RAcP Axis: Possible Role in Merkel Cell Carcinoma. International journal of molecular sciences 23 (7) (2022)
Anna-Stiina Meriläinen, Harri Jaakko Sihto, Virve S K Koljonen
Merkel cell polyomavirus is a passenger virus in both poroma and porocarcinoma. Journal of cutaneous pathology 49 (1) (2021)
Jenni Jaatinen, Tuukka Veija, Marko Salmikangas, Tom Böhling, Harri Jaakko Sihto, Virve Koljonen
ALK is frequently phosphorylated in Merkel cell carcinoma and associates with longer survival. PloS one 16 (5) (2021)
Benjamin Zacharias Sundqvist, Harri Jaakko Sihto, Maria von Willebrand, Tom O Böhling, Virve S K Koljonen
LRIG1 is a positive prognostic marker in Merkel cell carcinoma and Merkel cell carcinoma expresses epithelial stem cell markers. Virchows Archiv : an international journal of pathology (2021)
Anni Laine, Srikar G Nagelli, Caroline C Farrington, Umar Butt, Anna N Cvrljevic, Julia P Vainonen, Femke M Feringa, Tove J Grönroos, Prson Gautam, Sofia Khan, Harri Jaakko Sihto, Xi Qiao, Karolina Pavic, Denise C Connolly, Pauliina Kronqvist, Laura L Elo, Jochen Maurer, Krister Wennerberg, Rene H Medema, Heikki Joensuu, Emilia Peuhu, Karin E de Visser, Goutham Narla, Jukka Westermarck
CIP2A Interacts with TopBP1 and Drives Basal-Like Breast Cancer Tumorigenesis. Cancer research 81 (16) (2021)
Heidi M Haikala, Johanna M Anttila, Elsa Marques, Tiina Raatikainen, Mette Ilander, Henna Hakanen, Hanna Ala-Hongisto, Mariel Savelius, Diego Balboa, Björn von Eyss, Vilja Eskelinen, Pauliina Munne, Anni I Nieminen, Timo Otonkoski, Julia Schüler, Teemu D Laajala, Tero Aittokallio, Harri Jaakko Sihto, Johanna Mattson, Päivi Heikkilä, Marjut Leidenius, Heikki Joensuu, Mohamed El Missiry, Panu Kovanen, Martin Eilers, Joel D Leverson, Juha Klefström
Pharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapy. Nature communications 10 (1) (2019)
Heidi M Haikala, Johanna M Anttila, Elsa Marques, Tiina Raatikainen, Mette Ilander, Henna Hakanen, Hanna Ala-Hongisto, Mariel Savelius, Diego Balboa, Björn von Eyss, Vilja Eskelinen, Pauliina Munne, Anni I Nieminen, Timo Otonkoski, Julia Schüler, Teemu D Laajala, Tero Aittokallio, Harri Jaakko Sihto, Johanna Mattson, Päivi Heikkilä, Marjut Leidenius, Heikki Joensuu, Mohamed El Missiry, Panu Kovanen, Martin Eilers, Joel D Leverson, Juha Klefström
Publisher Correction: Pharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapy. Nature communications 10 (1) (2019)
Mika Pietilä, Pranshu Sahgal, Emilia Peuhu, Niklas Z Jäntti, Ilkka Paatero, Elisa Närvä, Hussein Al-Akhrass, Johanna Lilja, Maria Georgiadou, Olav M Andersen, Artur Padzik, Harri Jaakko Sihto, Heikki Joensuu, Matias Blomqvist, Irena Saarinen, Peter J Boström, Pekka Taimen, Johanna Ivaska
SORLA regulates endosomal trafficking and oncogenic fitness of HER2. Nature communications 10 (1) (2019)
Tatiana Lepikhova, Piia-Riitta Karhemo, Riku Louhimo, Bhagwan Yadav, Astrid Murumägi, Evgeny Kulesskiy, Mikko Kivento, Harri Jaakko Sihto, Reidar Grénman, Stina M Syrjänen, Olli Kallioniemi, Tero Aittokallio, Krister Wennerberg, Heikki Joensuu, Outi Monni
Drug-Sensitivity Screening and Genomic Characterization of 45 HPV-Negative Head and Neck Carcinoma Cell Lines for Novel Biomarkers of Drug Efficacy. Molecular cancer therapeutics 17 (9) (2018)
Riina Kaukonen, Anja Mai, Maria Georgiadou, Markku Saari, Nicola De Franceschi, Timo Betz, Harri Jaakko Sihto, Sami Ventelä, Laura Elo, Eija Jokitalo, Jukka Westermarck, Pirkko-Liisa Kellokumpu-Lehtinen, Heikki Joensuu, Reidar Grenman, Johanna Ivaska
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription. Nature communications 7 (2016)
Guillaume Jacquemet, Habib Baghirov, Maria Georgiadou, Harri Jaakko Sihto, Emilia Peuhu, Pierre Cettour-Janet, Tao He, Merja Perälä, Pauliina Kronqvist, Heikki Joensuu, Johanna Ivaska
L-type calcium channels regulate filopodia stability and cancer cell invasion downstream of integrin signalling. Nature communications 7 (2016)

Harri Jaakko Sihto.css-eqlu8i{font-size:small;padding-left:4px;} (Harri J Sihto, Harri Sihto)

Publication Activity (10 Years)

Top Topics

Top Venues

Harri Jaakko Sihto (Harri J Sihto, Harri Sihto)